News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
News Opinion Editor's Corner AHA 2023 What’s Going to Be Hot at AHA 2023 Shelley Wood November 07, 2023
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News AHA 2020 AFFIRM-AHF: IV Iron Supplementation Linked to Fewer Repeat Hospitalizations for HF L.A. McKeown November 13, 2020
News Conference News AHA 2019 Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial Shelley Wood November 18, 2019
News Conference News AHA 2017 AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More Shelley Wood November 09, 2017
News Conference News AHA 2016 Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients Yael L. Maxwell November 13, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Conference News AHA 2013 AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice November 24, 2013
News Conference News AHA 2013 Endovascular Revascularization Benefits PAD Patients When Added to Exercise Therapy Yael L. Maxwell November 18, 2013
News Conference News AHA 2012 OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia Jason Kahn November 06, 2012
News Conference News AHA 2012 Early Study Shows Positive Clinical Results with Novel Renal Denervation Device Jason Kahn November 04, 2012
News Conference News Supervised Exercise Improves Walking Outcomes Better Than Stenting in PAD November 16, 2011